Clinical trial
Clinical Assessment of the Benefits of the Combination Inuline, Choline and Silymarin in Mitigating the Symptomatology in Patients With Irritable Bowel Syndrome
NCT03174561 is registered in ClinicalTrials.gov with SC Fiterman Pharma SRL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Assessment of the Benefits of the Combination Inuline, Choline and Silymarin in Mitigating the Symptomatology in Patients With Irritable Bowel Syndrome
- Lead sponsor
- SC Fiterman Pharma SRL
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2017
- Completion date
- April 30, 2018
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.